GlobeNewswire Inc | May 20, 2021 08:00AM EDT

May 20, 2021

SOUTH SAN FRANCISCO, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (CNS) disorders, today announced that it will present at the following investor conferences in June:

Jefferies Virtual Healthcare ConferenceDate: Wednesday, June 2^nd at 2:30 p.m. ETWebcast: https://wsw.com/webcast/jeff174/vtgn/1876041Registration: To attend the virtual conference, please contact your Jefferies representative.

William Blair 41^st Annual Virtual Growth Stock ConferenceDate: Thursday, June 3^rd at 3:00 p.m. ETWebcast: https://wsw.com/webcast/blair58/vtgn/1959945Registration: To attend the virtual conference, please contact your William Blair representative.

For more information regarding these investor conferences, please visit the sponsors conference website.

About VistaGenVistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets. For more information, please visit www.vistagen.com and connect with VistaGen on Twitter, LinkedIn, and Facebook.

Company ContactsMark A. McPartland / Mark FlatherVistaGen Therapeutics, Inc.Phone: +1 (650) 577-3600Email:IR@vistagen.com